Opinion

Editor's Desk: Intrigues de Palais

Editor's Desk: Intrigues de Palais

Can agencies prove that regulations no longer hinder Grand Prix-level branded work?

You Have 100 Days To Make An Impact. What Are You Waiting For?

You Have 100 Days To Make An Impact. What Are You Waiting For?

Just landed a new job? You've got 100 days to make an impression. Here are some suggestions.

Could Marketing in Schools Help Save America's Health?

Could Marketing in Schools Help Save America's Health?

With an eye on the bottom line, hospitals and their marketing firms traditionally haven't spent much time on school campuses.

A Patient Journey Isn't the Solution to Pharma Marketing—It's the Beginning

A Patient Journey Isn't the Solution to Pharma Marketing—It's the Beginning

We need to view the patient journey as a starting place for much deeper analysis.

Three Technologies Driving Sales in Life Sciences

Three Technologies Driving Sales in Life Sciences

Multiple marketing channels offer an effective way to ensure that meaningful relationships can be developed with prospects and when done right can increase revenue by more than 10% while reducing costs by 25%, if not both

Pharmanormal activities

Pharmanormal activities

When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.

Is Digital Marketing a Dead-End Job?

Is Digital Marketing a Dead-End Job?

Either we need to stop calling it digital marketing (because digital is baked into business) and just consider it marketing. If we feel like we can't, then digital might very well be a dead-end job.

Apple Watch Changes the Health Wearables Game

Apple Watch Changes the Health Wearables Game

An early review of the Apple Watch

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.